Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
23.59
-4.40 (-15.72%)
At close: Apr 1, 2025, 4:00 PM
26.34
+2.75 (11.67%)
After-hours: Apr 1, 2025, 4:26 PM EDT

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
265135--
Enterprise Value
181215--
Last Close Price
23.5912.00--
PB Ratio
4.232.15--
P/TBV Ratio
2.152.15--
Debt / Equity Ratio
---2.08-1.40
Quick Ratio
6.956.953.112.78
Current Ratio
7.337.333.202.86
Return on Equity (ROE)
-59.37%-59.37%--
Return on Assets (ROA)
-18.39%-18.39%-61.63%-
Return on Capital (ROIC)
-26.38%-26.38%-110.58%-
Earnings Yield
-6.59%-12.95%--
Buyback Yield / Dilution
61.60%61.60%-1.36%-
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q